A Study of Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without Cirrhosis
Clinical trial NCT01749150 · COMPLETED
Trial details
- NCT number
- NCT01749150
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2015-02-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.